Lenarczyk, Radosław https://orcid.org/0000-0002-4680-6734
Proietti, Marco https://orcid.org/0000-0003-1452-2478
Scheitz, Jan F. https://orcid.org/0000-0001-5835-4627
Shah, Dipen
Siebert, Eberhard
Gorog, Diana A. https://orcid.org/0000-0002-9286-1451
Kowalczyk, Jacek
Bonaros, Nikolaos https://orcid.org/0000-0002-7656-5812
Ntaios, George https://orcid.org/0000-0002-0629-9248
Doehner, Wolfram
Van Mieghem, Nicolas M. https://orcid.org/0000-0002-2732-1205
Nardai, Sandor
Kovac, Jan
Fiszer, Roland
Lorusso, Roberto
Navarese, Eliano
Castrejón, Sergio
Rubboli, Andrea
Rivera-Caravaca, José Miguel https://orcid.org/0000-0003-0492-6241
Chieffo, Alaide
Lip, Gregory Y. H.
Article History
Accepted: 23 August 2024
First Online: 11 October 2024
Competing interests
: R. Lenarczyk has received consultant and lecture fees from Abbott and Boston Scientific. J.K. has received lecture fees from AstraZeneca and Pfizer. W.D. has received consulting fees and speaker honoraria from Aimediq, Bayer, Boehringer Ingelheim, Boston Scientific, Cardiomatics, Medtronic and Vifor Pharma; travel support from Pharmacosmos; and research support from Boehringer Ingelheim and Vifor Pharma. N.M.V.M. has received research grant support from Abbott Vascular, Boston Scientific, Daiichi–Sankyo, Medtronic, Meril, PulseCath BV and Teleflex; and has received advisory board fees from Abbott Vascular, Amgen, Anteris, Boston Scientific, Daiichi–Sankyo, JenaValve, Luma Vision, Medtronic, Pie Medical, PulseCath BV, Siemens and Teleflex. J.K. is a proctor and consultant and has a research contract for Boston Scientific. R. Lorusso is a consultant for LivaNova and Medtronic; is a member of the medical advisory board of Eurosets and Xenios; has received research grants from LivaNova and Medtronic; and has received a fee for presentation from Abiomed. J.M.R.-C. is a consultant for Idorsia Pharmaceuticals. A.C. is a speaker and consultant for Abbott Vascular, Abiomed, Boston Scientific, Biosensors, Medtronic and Menarini. G.Y.H.L. is a consultant and speaker for Anthos, BMS–Pfizer, Boehringer Ingelheim, Daiichi–Sankyo; no fees are received personally. The other authors declare no competing interests.
Free to read: This content has been made available to all.